List of Moviprep drug patents

Moviprep is owned by Salix Pharms.

Moviprep contains Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate.

Moviprep has a total of 2 drug patents out of which 0 drug patents have expired.

Moviprep was authorised for market use on 02 August, 2006.

Moviprep is available in for solution;oral dosage forms.

The generics of Moviprep are possible to be released after 01 September, 2024.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7169381 SALIX PHARMS Colon cleansing compositions and methods
Sep, 2024

(1 year, 6 months from now)

US7658914 SALIX PHARMS Colon cleansing compositions
Sep, 2024

(1 year, 6 months from now)

How can I launch a generic of MOVIPREP before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic